Photo of Vinay Prasad, MD, MPH

Vinay Prasad MD, MPH

Dr. Prasad specializes in caring for patients with hematologic malignancies, including Non-Hodgkin’s and Hodgkin’s lymphoma, chronic lymphocytic leukemia/lymphoma, mantle cell lymphoma and follicular lymphoma among others. He has advanced training in hematology (diseases of the blood and bone marrow) and oncology (cancer).  At OHSU, he is part of the lymphoma team, where he specializes in the care of people with hematologic malignancies, using chemotherapy, biological therapies, targeted therapies and immunotherapy to improve their health.

Dr. Prasad is nationally known for his research that seeks to improve the medical decisions doctors make, and improve the quality of evidence that doctors use to treat patients. He enjoys working with patients and their families to develop personalized treatment plans, and guide them through their care.  Dr. Prasad is the author of Ending Medical Reversal: Improving Outcomes, Saving Lives.

In his spare time, Dr. Prasad is an avid cyclist. He enjoys basketball, tennis, reading, gardening and occasionally binge-watching television.

Read more


  • M.D., University of Chicago 2009
  • M.P.H., Johns Hopkins University 2014
  • Residency:

    • Internal Medicine, Northwestern University, 2012
  • Fellowship:

    • Oncology, National Cancer Institute; Hematology, National Heart Lung Blood Institute, 2015
  • Certifications:

    • American Board of Internal Medicine (Internal Medicine) 2012; Medical Oncology and Hematology (2015)

Memberships and associations

  • American Society of Clinical Oncology


  • "Why do we continue to adopt medical practices based on pathophysiology alone when we should be insisting on clinical trials?" Journal of Clinical Epidemiology April 2014
  • "Response" Chest July 1 2015
  • "Prespecified falsification end points" JAMA - Journal of the American Medical Association January 16 2013
  • "The cardiovascular biomarker conundrum" JAMA - Journal of the American Medical Association November 16 2011
  • "Reclaiming the morbidity and mortality conference" Medical Humanities December 2010
  • "The facts are the facts" CMAJ December 11 2012
  • "Observational studies often make clinical practice recommendations" Journal of Clinical Epidemiology April 2013
  • "Holiday reading" CMAJ December 14 2010
  • "Dense breasts and legislating medicine" Cleveland Clinic Journal of Medicine December 2013
  • "Does the declining lethality of gunshot injuries mask a rising epidemic of gun violence in the United States?" Journal of General Internal Medicine  2014
  • "Statins, primary prevention, and overall mortality" Annals of Internal Medicine June 17 2014
  • "Failing to improve overall survival because post-protocol survival is long" Journal of Cancer Research and Clinical Oncology  2014
  • "How should we assess the value of innovative drugs in oncology? Lessons from cost-effectiveness analyses" Blood October 8 2015
  • "The reply" American Journal of Medicine March 2014
  • "Caution needed when predicting problem residents" Academic Medicine January 2011
  • "Open issues with open access publication" American Journal of Medicine July 2013
  • "Medical Debates and Medical Reversal" Journal of General Internal Medicine July 30 2015
  • "Long-term effects of the 2003 ACGME resident duty hour reform on hospital mortality" Mayo Clinic Proceedings  2014
  • "New frontiers for stroke prevention in atrial fibrillation" Cerebrovascular Diseases March 2012
  • "Steroids in infection" CMAJ January 11 2011
  • "Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer" European Journal of Cancer November 1 2015
  • "Primary chemoprevention of breast cancer" CMAJ June 16 2015
  • "Characteristics of cluster randomized trials" JAMA Internal Medicine February 25 2013
  • "Reversals of established medical practices" JAMA - Journal of the American Medical Association January 4 2012
  • "Mortality and treatment patterns among patients hospitalized with acute cardiovascular conditions during dates of national cardiology meetings" JAMA Internal Medicine February 1 2015
  • "Cardiovascular primary prevention" JAMA Internal Medicine April 23 2012
  • "Raise the bar even higher for primary prevention interventions - Reply" JAMA Internal Medicine September 24 2012
  • "Disease specific productivity of American Cancer Hospitals" PLoS One March 17 2015
  • "A medical burden of proof" BioSocieties March 2012
  • "The accelerated approval of oncologic drugs lessons from ponatinib" JAMA - Journal of the American Medical Association  2014

Additional information

Edit profile